» Articles » PMID: 2087483

Using Antagonists to Assess Neurochemical Coding of a Drug's Ability to Establish a Conditioned Place Preference

Overview
Publisher Elsevier
Date 1990 Nov 1
PMID 2087483
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Rats were given morphine as an agent of putative conditioning to establish a place preference. Doses of 4 and 8 mg/kg of morphine did establish reliable conditioned place preferences (CPP's). Other rats were given one of the doses of morphine and one of a number of antagonists in procedures designed to assess which antagonists would specifically block morphine's ability to establish a CPP indicative of positivity. Doses of naloxone and larger doses of naltrexone but not smaller ones did antagonize morphine's effects. A dose of the benzodiazepine antagonist Ro 15-1788 did not attenuate morphine's effects. It was concluded that morphine's positivity is dependent upon actions by way of receptors sensitive to naloxone and naltrexone, but that morphine's positivity is less sensitive to naltrexone's effects than morphine's analgesia.

Citing Articles

Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?.

Townsend E, Banks M CNS Drugs. 2020; 34(5):449-461.

PMID: 32248427 PMC: 7223115. DOI: 10.1007/s40263-020-00722-8.


The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence.

Stevenson G, Luginbuhl A, Dunbar C, LaVigne J, Dutra J, Atherton P Pharmacol Biochem Behav. 2015; 132:49-55.

PMID: 25735493 PMC: 4552603. DOI: 10.1016/j.pbb.2015.02.022.